The Significance of ERK5 Catalytic-independent Functions in Disease Pathways

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2023 Aug 21

PMID 37601096

Authors

Nhat-Tu Le

Affiliations

Soon will be listed here.

Abstract

Extracellular signal-regulated kinase 5 (ERK5), also known as BMK1 or MAPK7, represents a recent addition to the classical mitogen-activated protein kinase (MAPK) family. This family includes well-known members such as ERK1/2, c-Jun N-terminal kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK), as well as atypical MAPKs such as ERK3, ERK4, ERK7 (ERK8), and Nemo-like kinase (NLK). Comprehensive reviews available elsewhere provide detailed insights into ERK5, which interested readers can refer to for in-depth knowledge (Nithianandarajah-Jones et al., 2012; Monti et al., Cancers (Basel), 2022, 14). The primary aim of this review is to emphasize the essential characteristics of ERK5 and shed light on the intricate nature of its activation, with particular attention to the catalytic-independent functions in disease pathways.

Citing Articles

Targeting Cysteine Oxidation in Thrombotic Disorders.

Yang M, Silverstein R Antioxidants (Basel). 2024; 13(1).

PMID: 38247507 PMC: 10812781. DOI: 10.3390/antiox13010083.

References

Banerjee P, Kotla S, Velatooru L, Abe R, Davis E, Cooke J . Senescence-Associated Secretory Phenotype as a Hinge Between Cardiovascular Diseases and Cancer. Front Cardiovasc Med. 2021; 8:763930. PMC: 8563837. DOI: 10.3389/fcvm.2021.763930. View

Wagner E, Nebreda A . Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009; 9(8):537-49. DOI: 10.1038/nrc2694. View

Gorbachev A, Gasparian A, Gurova K, Gudkov A, Fairchild R . Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol. 2007; 37(8):2257-67. DOI: 10.1002/eji.200636708. View

Buschbeck M, Ullrich A . The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J Biol Chem. 2004; 280(4):2659-67. DOI: 10.1074/jbc.M412599200. View

Kamakura S, Moriguchi T, Nishida E . Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem. 1999; 274(37):26563-71. DOI: 10.1074/jbc.274.37.26563. View

Gomez N, Erazo T, Lizcano J . ERK5 and Cell Proliferation: Nuclear Localization Is What Matters. Front Cell Dev Biol. 2016; 4:105. PMC: 5031611. DOI: 10.3389/fcell.2016.00105. View

Hoang V, Matossian M, Ucar D, Elliott S, La J, Wright M . ERK5 Is Required for Tumor Growth and Maintenance Through Regulation of the Extracellular Matrix in Triple Negative Breast Cancer. Front Oncol. 2020; 10:1164. PMC: 7416559. DOI: 10.3389/fonc.2020.01164. View

Browne J, Pearson A, Zahr R, Niculescu-Duvaz I, Baines D, Dockrell M . TGF-beta activates ERK5 in human renal epithelial cells. Biochem Biophys Res Commun. 2008; 373(3):440-4. DOI: 10.1016/j.bbrc.2008.06.058. View

Kesavan K, Lobel-Rice K, Sun W, Lapadat R, Webb S, Johnson G . MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. J Cell Physiol. 2004; 199(1):140-8. DOI: 10.1002/jcp.10457. View

10.

Yang Q, Lee J . Targeting the BMK1 MAP kinase pathway in cancer therapy. Clin Cancer Res. 2011; 17(11):3527-32. PMC: 3107913. DOI: 10.1158/1078-0432.CCR-10-2504. View

11.

Paez-Mayorga J, Chen A, Kotla S, Tao Y, Abe R, He E . Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation. Front Cardiovasc Med. 2018; 5:125. PMC: 6135907. DOI: 10.3389/fcvm.2018.00125. View

12.

Kendrick T, Bogoyevitch M . Activation of mitogen-activated protein kinase pathways by the granulocyte colony-stimulating factor receptor: mechanisms and functional consequences. Front Biosci. 2006; 12:591-607. DOI: 10.2741/2085. View

13.

Liu F, Zhang H, Song H . Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis. Oncol Rep. 2016; 37(1):83-90. DOI: 10.3892/or.2016.5256. View

14.

Pereira D, Gomes S, Borralho P, Rodrigues C . MEK5/ERK5 activation regulates colon cancer stem-like cell properties. Cell Death Discov. 2019; 5:68. PMC: 6370793. DOI: 10.1038/s41420-019-0150-1. View

15.

de Jong P, Taniguchi K, Harris A, Bertin S, Takahashi N, Duong J . ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation. Nat Commun. 2016; 7:11551. PMC: 4873670. DOI: 10.1038/ncomms11551. View

16.

Zou J, Lei T, Guo P, Yu J, Xu Q, Luo Y . Mechanisms shaping the role of ERK1/2 in cellular senescence (Review). Mol Med Rep. 2018; 19(2):759-770. PMC: 6323238. DOI: 10.3892/mmr.2018.9712. View

17.

Banerjee P, Rosales J, Chau K, Nguyen M, Kotla S, Lin S . Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors. Front Cardiovasc Med. 2023; 10:1186679. PMC: 10272458. DOI: 10.3389/fcvm.2023.1186679. View

18.

Giurisato E, Lonardi S, Telfer B, Lussoso S, Risa-Ebri B, Zhang J . Extracellular-Regulated Protein Kinase 5-Mediated Control of p21 Expression Promotes Macrophage Proliferation Associated with Tumor Growth and Metastasis. Cancer Res. 2020; 80(16):3319-3330. PMC: 7611207. DOI: 10.1158/0008-5472.CAN-19-2416. View

19.

Terasawa K, Okazaki K, Nishida E . Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells. 2003; 8(3):263-73. DOI: 10.1046/j.1365-2443.2003.00631.x. View

20.

Takeishi Y, Huang Q, Abe J, Che W, Lee J, Kawakatsu H . Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res. 2001; 53(1):131-7. DOI: 10.1016/s0008-6363(01)00438-2. View